Although the pathway from MLH1 gene alterations to the dMMR/MSI-H phenotype has been largely elucidated, there is still limited knowledge regarding how this upstream genetic event systematically reshapes the tumor proteome, thereby influencing metabolic patterns, invasive potential, and immune microenvironment characteristics. Here, MLH1 is linked to neoplasm.